FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹487 Cr | ₹308 Cr | ₹257 Cr | ₹187 Cr | ₹162 Cr |
What is the latest Total Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹487 Cr |
| Mar2024 | ₹308 Cr |
| Mar2023 | ₹257 Cr |
| Mar2022 | ₹187 Cr |
| Mar2021 | ₹162 Cr |
How is Total Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹487 Cr | 58.21 | |
| Mar2024 | ₹308 Cr | 19.56 | |
| Mar2023 | ₹257 Cr | 37.59 | |
| Mar2022 | ₹187 Cr | 15.70 | |
| Mar2021 | ₹162 Cr | - | |
Compare Total Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹776.0 Cr | -8.4% | -15.9% | 109.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -8.4% |
-15.9% |
109.8% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses